{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-25-048619","form_type":"8-K","ticker":"HCWB","cik":"0001828673","company_name":"HCW Biologics Inc.","filed_at":"2025-04-01T23:59:59+00:00","discovered_at":"2026-05-14T18:02:49.983488+00:00","generated_at":"2026-05-24T01:05:33.716863+00:00","sec_items":["3.03","5.03","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"HCW Biologics approves 1-for-40 reverse stock split to regain Nasdaq compliance","bullets":["Reverse split effective April 11, 2025; outstanding shares reduced from ~44.9M to ~1.12M.","Purpose: raise bid price above $1.00 to regain compliance with Nasdaq Listing Rule 5810(c)(3)(A).","Authorized shares remain 250M; no change to par value ($0.0001).","Fractional shares rounded up; CUSIP changes to 40423R204.","Stockholders approved at special meeting March 31, 2025; board acted same day."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-25-048619","json":"https://secwatch.observer/filing/0000950170-25-048619.json","markdown":"https://secwatch.observer/filing/0000950170-25-048619.md","text":"https://secwatch.observer/filing/0000950170-25-048619.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025048619/0000950170-25-048619-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025048619/hcwb-20250401.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-24T01:05:33.716863+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"0700be13679af07ed6d47cdd45442fe67cf7684d","claim":"HCW Biologics Inc.: Filed Certificate of Amendment of Certificate of Incorporation to effect a 1-for-40 reverse stock split, with an effective date of April 11, 2025 (effective 2025-04-11).","evidence_excerpt":"The Company effected the Reverse Stock Split pursuant to the Company’s filing of an Certificate of Amendment of Certification of Incorporation with the Secretary of State of the State of Delaware on March 31, 2025","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/1828673/000095017025048619/0000950170-25-048619-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-04-11"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}